Showing results (2141-2150 of 2,156) with videos related to
Sort By:
Pageof 216
Scientific Reports|July 18, 2020
High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast ChinaYanhang Gao, Yanqing Li, Xiaowen Liu, et al.World Journal of Gastroenterology|June 23, 2017
Ischemic or toxic injury: A challenging diagnosis and treatment of drug-induced stenosis of the sigmoid colonZong-Ming Zhang, Xiang-Chun Lin, Li Ma, et al.Elife|January 20, 2026
Modeling and simulation of neocortical micro- and mesocircuitry (Part I, anatomy)Michael W Reimann, Sirio Bolaños-Puchet, Jean-Denis Courcol, et al.Cell Reports|March 3, 2023
Thalamic control of sensory processing and spindles in a biophysical somatosensory thalamoreticular circuit model of wakefulness and sleepElisabetta Iavarone, Jane Simko, Ying Shi, et al.Signal Transduction and Targeted Therapy|September 26, 2021
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gammaJiejie Geng, Liang Chen, Yufeng Yuan, et al.Plos Biology|November 5, 2024
Community-based reconstruction and simulation of a full-scale model of the rat hippocampus CA1 regionArmando Romani, Alberto Antonietti, Davide Bella, et al.The Lancet. Haematology|October 8, 2025
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort studyWei Yin, Xiaoyu Yan, Jiaoyang Cai, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 4, 2019
Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of lifeZeng Qing Guo, Jia Mi Yu, Wei Li, et al.Signal Transduction and Targeted Therapy|April 13, 2025
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.Signal Transduction and Targeted Therapy|May 18, 2021
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Zhao-Hui Zheng, Ding Wei, et al.Pageof 216